Fig. 2From: Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trialIntervention and assessment schedule for the trial according to the Recommendations for Interventional Trials (SPIRIT)Back to article page